BG108447A - Process for the preparation of amorphous cilastatin sodium - Google Patents

Process for the preparation of amorphous cilastatin sodium

Info

Publication number
BG108447A
BG108447A BG108447A BG10844703A BG108447A BG 108447 A BG108447 A BG 108447A BG 108447 A BG108447 A BG 108447A BG 10844703 A BG10844703 A BG 10844703A BG 108447 A BG108447 A BG 108447A
Authority
BG
Bulgaria
Prior art keywords
preparation
cilastatin sodium
amorphous
amorphous cilastatin
sodium
Prior art date
Application number
BG108447A
Other languages
Bulgarian (bg)
English (en)
Inventor
Yatendra Kumar
Om TYAGI
Amit Rohtagi
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of BG108447A publication Critical patent/BG108447A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/02Monohydroxylic acyclic alcohols
    • C07C31/04Methanol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • C07C319/28Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
BG108447A 2001-05-18 2003-12-12 Process for the preparation of amorphous cilastatin sodium BG108447A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN593DE2001 2001-05-18

Publications (1)

Publication Number Publication Date
BG108447A true BG108447A (en) 2005-03-31

Family

ID=11097060

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108447A BG108447A (en) 2001-05-18 2003-12-12 Process for the preparation of amorphous cilastatin sodium

Country Status (24)

Country Link
US (1) US20040152780A1 (no)
EP (1) EP1395530A4 (no)
JP (1) JP2004526805A (no)
KR (1) KR20040044409A (no)
CN (1) CN1522235A (no)
AP (2) AP1511A (no)
AR (1) AR036017A1 (no)
BG (1) BG108447A (no)
BR (1) BR0209843A (no)
CA (1) CA2447788A1 (no)
CZ (1) CZ20033352A3 (no)
EA (1) EA005947B1 (no)
EE (1) EE200300567A (no)
HR (1) HRP20031052A2 (no)
HU (1) HUP0400825A2 (no)
IL (1) IL158945A0 (no)
MX (1) MXPA03010547A (no)
NO (1) NO20035138D0 (no)
NZ (1) NZ529625A (no)
OA (1) OA12607A (no)
PL (1) PL367937A1 (no)
SK (1) SK15082003A3 (no)
WO (1) WO2002094742A1 (no)
ZA (1) ZA200309287B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2402312B1 (en) 2005-11-09 2013-07-17 Orchid Chemicals&Pharmaceuticals Limited An improved process for the preparation of cilastatin acid
WO2011080648A1 (en) * 2010-01-01 2011-07-07 Orchid Chemicals And Pharmaceuticals Limited An improved process for the preparation of cilastatin sodium
CN102675175B (zh) * 2011-03-08 2014-02-19 深圳市海滨制药有限公司 一种西司他丁的分离纯化方法
US11324804B2 (en) 2016-11-18 2022-05-10 Sepsia Therapeutics, S.L. Combined CD6 and imipenem therapy for treatment of infectious diseases and related inflammatory processes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147868A (en) * 1978-07-24 1992-09-15 Merck & Co., Inc. Thienamycin renal peptidase inhibitors
US4292436A (en) * 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
EP0441371B1 (en) * 1990-02-08 1995-01-25 Sumitomo Chemical Company, Limited Process for preparing haloketo acid derivatives
US5166417A (en) * 1990-09-04 1992-11-24 Lonza Ltd. Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid
CA2056840A1 (en) * 1990-12-17 1992-06-18 Thomas Meul Process for the production of dimethylcyclopropanecarboxylic acid
DE59209523D1 (de) * 1991-07-26 1998-11-19 Lonza Ag Gentechnologisches Verfahren zur Herstellung von S-(+)-2,2-Dimethylcyclopropancarboxamid mittels Mikroorganismen
US5245069A (en) * 1992-10-27 1993-09-14 Merck & Co., Inc. Process for the preparation of bis(aryl)-phosphorohalidates
IN191798B (no) * 2000-11-03 2004-01-03 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
EA005947B1 (ru) 2005-08-25
MXPA03010547A (es) 2004-05-27
CN1522235A (zh) 2004-08-18
EA200301225A1 (ru) 2004-06-24
AR036017A1 (es) 2004-08-04
PL367937A1 (en) 2005-03-07
EE200300567A (et) 2004-04-15
EP1395530A1 (en) 2004-03-10
US20040152780A1 (en) 2004-08-05
SK15082003A3 (sk) 2004-06-08
NO20035138D0 (no) 2003-11-18
CA2447788A1 (en) 2002-11-28
AP2003002913A0 (en) 2003-12-31
OA12607A (en) 2006-06-08
CZ20033352A3 (en) 2004-06-16
HUP0400825A2 (hu) 2004-08-30
IL158945A0 (en) 2004-05-12
EP1395530A4 (en) 2006-01-18
BR0209843A (pt) 2004-08-24
HRP20031052A2 (en) 2004-06-30
KR20040044409A (ko) 2004-05-28
AP2003002912A0 (en) 2002-05-17
JP2004526805A (ja) 2004-09-02
ZA200309287B (en) 2004-07-22
NZ529625A (en) 2006-02-24
WO2002094742A1 (en) 2002-11-28
AP1511A (en) 2005-12-20

Similar Documents

Publication Publication Date Title
MXPA04004604A (es) Proceso para la preparacion de imipenem cristalino.
YU42803A (sh) Novi kristalni oblici atorvastatin hemi-kalcijuma i postupci za njihovo pripremanje kao i novi postupci za pripremanje drugih oblika
HUP0402247A3 (en) Antibodies to cd40
UA74409C2 (uk) Спосіб одержання тіотропійброміду, який має антихолінергічну дію
HK1028401A1 (en) A process for the reduction of oxiranyl epothilones to olefinic epothilones
TW200508201A (en) Novel process for the preparation of roflumilast
PL366905A1 (en) Crystalline forms of fluvastatin sodium
SI1423360T1 (sl) Postopek za izdelavo cilastatina
HUP0302530A3 (en) Process for the purification of 2-nitro-4-methylsulphonylbenzoic acid
MXPA03010498A (es) Proceso para la preparacion de imipenem.
AP2003002912A0 (en) Process for the preparation of amorphouse cilastatin sodium
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
MXPA03010548A (es) Proceso para el aislamiento de imipenem cristalino.
IL155733A0 (en) Improved process for production of gabapentin intermediate
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
GB2394582B (en) Process for transmitting direction or similar instructions to persons
AU2001266323A1 (en) Process for the production of calcium pantothenate
AU2002242942A1 (en) 3-0-'alfa-l-rhamnopyranosyl- (1-2) -alpha-l-rhamnopyranosyl- (1-4) -3beta-d-glucopyranosyl!-25 (s) -spirost an-3beta-ol, process for its isolation, and its use as immunomodulator
AU8711701A (en) Process to produce halo-4-phenoxyquinolines
TW200407314A (en) Preparation of 4, 6-dichloro-5-fluoropyrimidine
GB2381788A (en) A process for preparation of an ester using a polyanaline salt as catalyst
AU2002232297A1 (en) Process to produce paroxetine
LT2004018A (en) Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
HU0001287D0 (en) New intermediate and process for its production
EP1482054A4 (en) PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ALLAS